Israeli biotech company Bonus BioGroup is growing live bones from patients’ own fat cells.
The announcement was made in a statement to the Tel Aviv Stock Exchange and Bonus Biogroup presented its results at the International Conference on Oral and Maxillofacial Surgery in Spain yesterday.
Bonus BioGroup’s CEO Shai Meretski, who previously founded Pluristem Therapeutics, an advanced Israeli biomedical company that works with stem cells, told Reuters, “For the first time worldwide, reconstruction of deficient or damaged bone tissue is achievable by growing viable human bone graft in a laboratory, and transplanting it back to the patient in a minimally invasive surgery via injection.”
The transplant “was 100% successful in all 11 patients,” Ora Burger, the VP of regulation affairs, told Reuters. “Now we are going to conduct a clinical study in the extremities, long bones.”
For more information, please click on the following link.